Quantum Neural Technologies (QNT), founded in 2021 by Drs. A. Tsikas and T. Psarogiannakopoulos, is an elite R&D hub of 11 Greek scientists bridging quantum mechanics with neural networks. We deliver a high-performance simulation environment featuring specialized engines for circuit optimization, ansatz generation, and noise simulation to ensure industrial usability.

A core focus is the Protein Folding Problem, where we utilize proprietary VQA-based topologies to unlock transformative solutions for drug discovery and biotechnology. Additionally, QNT has developed a patent-pending protocol for Certified True Randomness.

This device-independent approach guarantees cryptographic security through statistical analysis, treating hardware as a "black box" while remaining fully noise-tolerant. By merging hybrid quantum-classical architectures with practical, scalable applications, QNT transforms complex quantum potential into immediate, real-world industrial impact.